Jan 08, 2024 / 10:15PM GMT
Jessica Macomber Fye - JPMorgan Chase & Co, Research Division - Analyst
Good afternoon, everyone. I'm Jess Fye. I'm a Senior Biotech Analyst at JPMorgan, and we're continuing the 42nd Annual Healthcare Conference today with Jazz. I'm joined by the company's Chairman and CEO, Bruce Cozadd, who's going to give a presentation. And then we're going to move into Q&A with a couple of other members of management team on stage.
If you are in the room and you want to ask a question, you can raise your hand and someone will bring you a mic or you can always use the portal to send me questions on the iPad up here. So with that, let me turn it over to Bruce.
Bruce C. Cozadd - Jazz Pharmaceuticals plc - Co-Founder, Chairman & CEO
Thank you, Jess, and thank you all for being here. So the 42nd Annual JPMorgan Healthcare Conference, I've only been at the last 33, so I missed a couple, the last 20 representing Jazz Pharmaceuticals. And I have to say, I'm delighted to be here to give you an update on the accomplishments of the company in 2023, but more
Jazz Pharmaceuticals PLC at JPMorgan Healthcare Conference Transcript
Feb 07, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers